Wiltrom (6767) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 台微醫

Wiltrom (6767) reported revenue of NT$29.7 million for Oct 2026, +29.1% year on year and +2.6% from the previous month. Revenue for Jan–Oct 2026 was NT$279.5 million (+3.3% year on year).

In Oct 2026, it ranked No. 119 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$30.8 million24/10Nov 2024 NT$32.4 millionDec 2024 NT$31.2 millionJan 2025 NT$30.2 millionFeb 2025 NT$21 million25/02Mar 2025 NT$30.5 millionApr 2025 NT$25.1 millionMay 2025 NT$25.8 millionJun 2025 NT$31.7 million25/06Jul 2025 NT$30.8 millionAug 2025 NT$29.1 millionSep 2025 NT$23.4 millionOct 2025 NT$23 million25/10Nov 2025 NT$20.6 millionDec 2025 NT$20.7 millionJan 2026 NT$30.7 millionFeb 2026 NT$20 million26/02Mar 2026 NT$31.6 millionApr 2026 NT$28.6 millionMay 2026 NT$26.3 millionJun 2026 NT$29.4 million26/06Jul 2026 NT$25.9 millionAug 2026 NT$28.4 millionSep 2026 NT$28.9 millionOct 2026 NT$29.7 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$29.7 million+29.1%+2.6%
Sep 2026NT$28.9 million+23.8%+1.8%
Aug 2026NT$28.4 million-2.2%+10.0%
Jul 2026NT$25.9 million-16.0%-11.9%
Jun 2026NT$29.4 million-7.4%+11.7%
May 2026NT$26.3 million+1.9%-8.0%
Apr 2026NT$28.6 million+13.9%-9.6%
Mar 2026NT$31.6 million+3.6%+57.8%
Feb 2026NT$20 million-4.7%-34.8%
Jan 2026NT$30.7 million+1.8%+48.7%
Dec 2025NT$20.7 million-33.8%+0.2%
Nov 2025NT$20.6 million-36.2%-10.3%
Oct 2025NT$23 million-25.3%-1.6%
Sep 2025NT$23.4 million-16.7%-19.6%
Aug 2025NT$29.1 million-13.9%-5.5%
Jul 2025NT$30.8 million+9.4%-2.9%
Jun 2025NT$31.7 million+39.9%+22.9%
May 2025NT$25.8 million-12.9%+2.8%
Apr 2025NT$25.1 million+6.3%-17.8%
Mar 2025NT$30.5 million+7.8%+45.2%
Feb 2025NT$21 million+15.5%-30.4%
Jan 2025NT$30.2 million+7.5%-3.2%
Dec 2024NT$31.2 million+28.1%-3.6%
Nov 2024NT$32.4 million+31.2%+5.1%
Oct 2024NT$30.8 million+34.1%+9.8%

Jan–Oct 2026 cumulative: NT$279.5 million (+3.3% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Wiltrom vs PEC / Wiltrom vs Lotus Pharm / Wiltrom vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16